SCHEMBL505866

SCHEMBL505866

COC(=O)c1ccc(-c2cccc(F)c2F)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.54
HDAC1 Q13547 1/20 0.54
HDAC2 Q92769 1/20 0.54
HDAC8 Q9BY41 1/20 0.54
HDAC6 Q9UBN7 1/20 0.54
KMT2A Q03164 3/20 0.50
ALDH1A1 P00352 2/20 0.50
EGFR P00533 1/20 0.50
PTGS1 P23219 1/20 0.50
SLC6A4 P31645 1/20 0.50
SLC6A3 Q01959 1/20 0.50
MAPT P10636 4/20 0.48
NPC1 O15118 4/20 0.48
RAB9A P51151 4/20 0.48
PTPN1 P18031 2/20 0.48
HTT P42858 2/20 0.48
PTPRC P08575 1/20 0.48
PTPRF P10586 1/20 0.48
CDC25B P30305 1/20 0.48
KDM4E B2RXH2 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12812057 0.87 ALDH1A1 (0.61) KMT2AALDH1A1EGFRPTGS1SLC6A4
SCHEMBL10091247 0.80 CYP1A2 (0.48) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL505283 0.80 TTR (0.65) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL5943856 0.79 HDAC6 (0.59) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL5583011 0.78 MKNK1 (0.53) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL16502530 0.78 NPC1 (0.47) KMT2AALDH1A1MAPTNPC1RAB9A
SCHEMBL27708108 0.78 EGFR (0.71) KMT2AALDH1A1EGFRSLC6A4SLC6A3
SCHEMBL17141847 0.77 MAPT (0.77) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL9723083 0.77 HDAC3 (0.58) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL10268717 0.77 CYP4F2 (0.51) HDAC3HDAC1HDAC2HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113396145-A PFKFB3 inhibitors and uses thereof 盖罗发现有限责任公司 2021-09-14 CN disclosed
CN-104030987-B DIHYDROOROTATE DEHYDROGENASE INHIBITORS 默克雪兰诺有限公司 2017-04-12 CN disclosed
US-9006454-B2 Dihydroorotate dehydrogenase inhibitors MERCK SERONO S.A. (CH) 2015-04-14 US disclosed
US-9006454-B2 Dihydroorotate dehydrogenase inhibitors MERCK SERONO S.A. (CH) 2015-04-14 US disclosed
US-9006454-B2 Dihydroorotate dehydrogenase inhibitors MERCK SERONO S.A. (CH) 2015-04-14 US disclosed
US-20120028959-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO S.A. (CH) 2012-02-02 US disclosed
US-20120028959-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO S.A. (CH) 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028959-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS DHODH, FH, DPYD HDAC3 1169/4885HDAC1 333/4885HDAC2 738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.